Susceptibility to Simian Immunodeficiency Virus Ex Vivo Predicts Outcome of a Prime-Boost Vaccine After SIVmac239 Challenge
2009 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Susceptibility to Simian Immunodeficiency Virus Ex Vivo Predicts Outcome of a Prime-Boost Vaccine After SIVmac239 Challenge
Ochieng, W.; Sauermann, U.; Schulte, R.; Suh, Y.-S.; Kim, K. S.; Sung, Y. C. & Hunsmann, G. et al. (2009)
Journal of Acquired Immune Deficiency Syndromes, 52(2) pp. 162-169. DOI: https://doi.org/10.1097/QAI.0b013e3181b22f4a
